Yoskowitz Marc J — SEC Form 4 filings
SEC reporting owner CIK 1617306. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-09 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Keenova Therapeutics plc | Director | 5 | — | — | 8 |
| Mereo BioPharma Group plc (MREO) | Director | 3 | — | — | 6 |
Form 4 filings — Yoskowitz Marc J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Keenova Therapeutics plc | Grant/award (A): 4,406 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Keenova Therapeutics plc | Option exercise (M): 3,579 · Tax withholding (F): 825 · Disposition to issuer (D): 2,930 (derivative) · Option exercise (M): 3,579 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 66,000 (derivative) @ $0 · Grant/award (A): 96,163 (derivative) | EDGAR |
| 2026-02-25 | 4 | Keenova Therapeutics plc | Grant/award (A): 5,312 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | Mallinckrodt plc | Grant/award (A): 1,354 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | Mallinckrodt plc | Grant/award (A): 4,062 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 13,719 (derivative) | EDGAR |
| 2024-02-09 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 14,139 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1617306 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →